Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.51B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$411M |
| 3 |
Microsoft
MSFT
|
+$300M |
| 4 |
Apple
AAPL
|
+$284M |
| 5 |
Visa
V
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$254M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$178M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$177M |
| 4 |
Blackstone
BX
|
+$139M |
| 5 |
Exelon
EXC
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.38% |
| 2 | Technology | 11.34% |
| 3 | Miscellaneous | 10.58% |
| 4 | Energy | 8.74% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
Precision BioSciences
DTIL
$175M
| $66K | ﹤0.01% |
157
+130
| +481% | +$40.8K |
2019 Q2
2 quarters
|
|
3702
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.76B
| $66K | ﹤0.01% |
1,916
-770
| -29% | -$25.3K |
2018 Q1
7 quarters
|
|
3703
PUT
Marker Therapeutics
MRKR
$17.5M
| $66K | ﹤0.01% |
2,280
+750
| +49% | +$27.3K |
2019 Q3
1 quarter
|
|
3704
Team
TISI
$130M
| $66K | ﹤0.01% |
413
+93
| +29% | +$15.8K |
2013 Q2
26 quarters
|
|
3705
UNIFI
UFI
$121M
| $66K | ﹤0.01% |
2,638
-1,188
| -31% | -$28.7K |
2015 Q1
19 quarters
|
|
3706
Xenon Pharmaceuticals
XENE
$3.77B
| $66K | ﹤0.01% |
5,000
-1,198
| -19% | -$12.6K |
2018 Q1
7 quarters
|
|
|
VBIV
3707
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $66K | ﹤0.01% |
1,577
+76
| +5% | +$1.66K |
2018 Q3
5 quarters
|
|
|
CAPD
3708
DELISTED
iPath Shiller CAPE ETN
CAPD
| $66K | ﹤0.01% |
4,460
-430
| -9% | -$6.13K |
2019 Q2
2 quarters
|
|
|
BGG
3709
DELISTED
Briggs & Stratton Corp.
BGG
| $66K | ﹤0.01% |
9,773
-1,223
| -11% | -$7.5K |
2013 Q2
26 quarters
|
|
|
BDSI
3710
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $66K | ﹤0.01% |
10,436
+3,108
| +42% | +$18.3K |
2018 Q2
6 quarters
|
|
3711
Enel Chile
ENIC
$5.71B
| $65K | ﹤0.01% |
13,568
-2,721
| -17% | -$11.7K |
2019 Q2
2 quarters
|
|
|
IMVP
3712
Invesco India ETF
IMVP
$93.7M
| $65K | ﹤0.01% |
3,290
-110
| -3% | -$2.67K |
2013 Q2
26 quarters
|
|
3713
Spok Holdings
SPOK
$223M
| $65K | ﹤0.01% |
5,251
+1,626
| +45% | +$19.2K |
2014 Q1
23 quarters
|
|
|
BPYU
3714
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $65K | ﹤0.01% |
3,546
+3,001
| +551% | +$56.8K |
2018 Q3
5 quarters
|
|
|
SSI
3715
DELISTED
Stage Stores Inc
SSI
| $65K | ﹤0.01% |
+8,000
| New | +$31K |
2019 Q4
0 quarters
|
|
|
SSI
3716
PUT
DELISTED
Stage Stores Inc
SSI
| $65K | ﹤0.01% |
+8,000
| New | +$31K |
2019 Q4
0 quarters
|
|
3717
BayCom
BCML
$337M
| $64K | ﹤0.01% |
2,813
+388
| +16% | +$8.57K |
2018 Q2
6 quarters
|
|
|
DOYU
3718
DouYu International Holdings
DOYU
$131M
| $64K | ﹤0.01% |
+762
| New | +$59.2K |
2019 Q4
0 quarters
|
|
3719
Global X Lithium & Battery Tech ETF
LIT
$1.43B
| $64K | ﹤0.01% |
2,331
-183
| -7% | -$4.67K |
2013 Q2
26 quarters
|
|
3720
iShares MSCI China ETF
MCHI
$6B
| $64K | ﹤0.01% |
1,000
+200
| +25% | +$12K |
2018 Q3
5 quarters
|
|
|
MITT
3721
TPG Mortgage Investment Trust
MITT
$182M
| $64K | ﹤0.01% |
1,378
+426
| +45% | +$19.6K |
2019 Q2
2 quarters
|
|
3722
Penske Automotive Group
PAG
$13.3B
| $64K | ﹤0.01% |
1,282
-172
| -12% | -$8.5K |
2014 Q2
22 quarters
|
|
3723
SunCoke Energy
SXC
$827M
| $64K | ﹤0.01% |
10,306
-3,198
| -24% | -$17.8K |
2013 Q2
26 quarters
|
|
3724
Verastem
VSTM
$715M
| $64K | ﹤0.01% |
3,942
+3,259
| +477% | +$46.8K |
2019 Q3
1 quarter
|
|
3725
Q32 Bio
QTTB
$246M
| $64K | ﹤0.01% |
173
+52
| +43% | +$14.9K |
2019 Q2
2 quarters
|
|
Similar funds
Bank of Montreal's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of Montreal held 5,174 positions worth $133B, up 15% from $116B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of Montreal deployed $8.58B of net new capital in Q4 2019, opening 425 new positions and adding to 2,835 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 28% a quarter earlier, followed by Technology and Miscellaneous.
On the sell side, the largest reduction was Apollo Global Management, an estimated $254M trimmed.
- Bank of Montreal's largest Q4 2019 buy was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.51B increase.
- Bank of Montreal's biggest Q4 2019 reduction was Apollo Global Management, cutting an estimated $254M.
- Bank of Montreal fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $125M.
- Bank of Montreal's ten largest holdings make up 20% of its $133B portfolio in Q4 2019.
- Bank of Montreal opened 425 new positions and closed 298 in Q4 2019.
- Bank of Montreal's portfolio value rose 15% quarter-over-quarter to $133B.
Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.